Related Experiment Video
Updated: Jun 23, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 19, 2013
Chemoprevention of prostate cancer
1Section of Urologic Oncology, Glickman Urological Institute and Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. kleine@ccf.org
Abstract:
Prostate cancer is an attractive target for chemoprevention because of its ubiquity, treatment-related morbidity, long latency between premalignant lesions and clinically evident cancer, and defined molecular pathogenesis. The Prostate Cancer Prevention Trial has provided the first firm evidence that this cancer can be prevented by a relatively nontoxic oral agent. Additional agents, many of which are antioxidants with antiandrogenic effects, are being tested (or soon will be) in large clinical trials. The current body of evidence is insufficient to make a routine recommendation of any dietary or nutritional supplement for the prevention of prostate cancer.
Insights
Chemoprevention can prevent prostate cancer using oral agents. However, current evidence is insufficient to recommend dietary supplements for routine prostate cancer prevention.
Area of Science:
- Oncology
- Preventive Medicine
- Molecular Pathogenesis
Background:
- Prostate cancer is a common malignancy with a long latency period.
- Chemoprevention is a promising strategy due to the cancer's molecularly defined pathogenesis and treatment morbidities.
Purpose of the Study:
- To review the evidence for prostate cancer chemoprevention.
- To assess the role of oral agents and supplements in preventing prostate cancer.
Main Methods:
- Review of findings from the Prostate Cancer Prevention Trial.
- Discussion of ongoing and planned clinical trials for chemopreventive agents.
- Evaluation of the evidence for antioxidants and antiandrogenic compounds.
Main Results:
- The Prostate Cancer Prevention Trial demonstrated that prostate cancer can be prevented by a non-toxic oral agent.
- Several agents, including antioxidants with antiandrogenic properties, are under investigation in large clinical trials.
Conclusions:
- Chemoprevention is a viable strategy for prostate cancer.
- Current evidence does not support routine recommendations for dietary or nutritional supplements for prostate cancer prevention.
Related Concept Videos
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

